Dr. Jacob Rajfer, MD

Dr. Rajfer practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Rajfer's NPI, 1225057508, was assigned on July 18, 2006. Dr. Rajfer graduated from Feinberg School of Medicine in 1972. Dr. Rajfer holds California license G24703.

Dr. Rajfer's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Rajfer's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Rajfer is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Rajfer to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rajfer practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Rajfer's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Rajfer is board certified in urology by the American Board of Urology. Dmand AI has Dr. Rajfer's licenses on file in 4 states: California, Nevada, Maryland and Colorado.

Dmand AI lists enlarged prostate, erectile dysfunction, prostate inflammation or infection and testicular dysfunction among the conditions Dr. Rajfer treats.

CMS data shows 78 Medicare services from Dr. Rajfer across 5 procedure codes in 2024, for 47 Medicare patients. Medicare paid $4,641 for them. Every service was in an office.

CMS counts 47 Medicare patients who saw Dr. Rajfer in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rajfer's median patient age at 56, with 0% women.

In 2024, Dr. Rajfer wrote 74 Medicare Part D claims for 22 patients. 89% of them were for generic drugs. CMS names the drug for 39 of them, across 2 drugs with 11 or more claims each, at $848 in total drug cost. In 2023, CMS named 47 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 64 out of 100 for Dr. Rajfer for performance year 2024, reported as part of a group. Dr. Rajfer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Rajfer, published from 2013 to 2025. 2014 was the busiest year, with 2. Dr. Rajfer's most frequent co-authors are Sabine Nguyen, DO, Ronald S. Swerdloff, MD and Christina Wang, MD.

CMS Open Payments shows 19 general payments to Dr. Rajfer from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Rochester Medical Corporation paid the most, $198.

Dr. Rajfer graduated from Feinberg School of Medicine in 1972.

Dr. Rajfer is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.